These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20063300)

  • 1. Receipt of cardiac medications upon discharge among men and women with acute coronary syndrome and nonobstructive coronary artery disease.
    Ramanath VS; Armstrong DF; Grzybowski M; Rahnama-Mohagdam S; Tamhane UU; Gordon K; Froehlich JB; Eagle KA; Jackson EA
    Clin Cardiol; 2010 Jan; 33(1):36-41. PubMed ID: 20063300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Medication Use in Patients with Acute Myocardial Infarction and Nonobstructive Coronary Artery Disease.
    Adatia F; Galway S; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
    J Womens Health (Larchmt); 2017 Nov; 26(11):1185-1192. PubMed ID: 28384014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex Differences in Cardiac Medication Use Post-Catheterization in Patients Undergoing Coronary Angiography for Stable Angina with Nonobstructive Coronary Artery Disease.
    Galway S; Adatia F; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
    J Womens Health (Larchmt); 2017 Sep; 26(9):976-983. PubMed ID: 28384013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.
    Maddox TM; Ho PM; Roe M; Dai D; Tsai TT; Rumsfeld JS
    Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):632-41. PubMed ID: 20923997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry.
    Pitts R; Daugherty SL; Tang F; Jones P; Ho PM; Tsai TT; Spertus J; Maddox TM
    Clin Cardiol; 2017 Jun; 40(6):347-355. PubMed ID: 28387960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
    El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
    Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
    Lee HY; Cooke CE; Robertson TA
    J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with acute coronary syndrome and nonobstructive coronary artery disease in the real world are markedly undertreated.
    De Ferrari GM; Leonardi S; Baduena L; Chieffo E; Lesce A; Repetto A; Previtali M
    J Cardiovasc Med (Hagerstown); 2011 Oct; 12(10):700-8. PubMed ID: 21738050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and therapeutic implications of statin and aspirin therapy in individuals with nonobstructive coronary artery disease: results from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter registry) registry.
    Chow BJ; Small G; Yam Y; Chen L; McPherson R; Achenbach S; Al-Mallah M; Berman DS; Budoff MJ; Cademartiri F; Callister TQ; Chang HJ; Cheng VY; Chinnaiyan K; Cury R; Delago A; Dunning A; Feuchtner G; Hadamitzky M; Hausleiter J; Karlsberg RP; Kaufmann PA; Kim YJ; Leipsic J; LaBounty T; Lin F; Maffei E; Raff GL; Shaw LJ; Villines TC; Min JK;
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):981-9. PubMed ID: 25676000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of angiotensin-converting enzyme inhibitors and beta blockers on clinical outcomes in patients with and without coronary artery obstructions at angiography (from a Register-Based Cohort Study on Acute Coronary Syndromes).
    Manfrini O; Morrell C; Das R; Barth JH; Hall AS; Gale CP; Cenko E; Bugiardini R;
    Am J Cardiol; 2014 May; 113(10):1628-33. PubMed ID: 24698468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [SECONDARY PREVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME HOSPITALIZED IN INTERNAL MEDICINE DEPARTMENTS].
    Yahia DH; Pereg D; Lishner M; Elis A
    Harefuah; 2015 May; 154(5):299-302, 339-40. PubMed ID: 26168639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in preventive medical therapies and CV risk factors after CT angiography.
    Cheezum MK; Hulten EA; Smith RM; Taylor AJ; Kircher J; Surry L; York M; Villines TC
    JACC Cardiovasc Imaging; 2013 May; 6(5):574-81. PubMed ID: 23582355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women tolerate drug therapy for coronary artery disease as well as men do, but are treated less frequently with aspirin, beta-blockers, or statins.
    Enriquez JR; Pratap P; Zbilut JP; Calvin JE; Volgman AS
    Gend Med; 2008 Mar; 5(1):53-61. PubMed ID: 18420166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between in-hospital guideline adherence and postdischarge major adverse outcomes of patients with acute coronary syndrome in Vietnam: a prospective cohort study.
    Nguyen T; Le KK; Cao HTK; Tran DTT; Ho LM; Thai TND; Pham HTK; Pham PT; Nguyen TH; Hak E; Pham TT; Taxis K
    BMJ Open; 2017 Oct; 7(10):e017008. PubMed ID: 28982823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing prevention and guideline-concordant care in Montenegro.
    Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
    Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-reported use of evidence-based medicine and smoking cessation 6 - 9 months after acute coronary syndrome: a single-centre perspective.
    Griffiths B; Lesosky M; Ntsekhe M
    S Afr Med J; 2014 Jun; 104(7):483-7. PubMed ID: 25214049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Secondary Prevention Medication on the Prognosis in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.
    Abdu FA; Liu L; Mohammed AQ; Xu B; Yin G; Xu S; Xu Y; Che W
    J Cardiovasc Pharmacol; 2020 Dec; 76(6):678-683. PubMed ID: 33284169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential for coronary CT angiography to tailor medical therapy beyond preventive guideline-based recommendations: insights from the ROMICAT I trial.
    Pursnani A; Schlett CL; Mayrhofer T; Celeng C; Zakroysky P; Bamberg F; Nagurney JT; Truong QA; Hoffmann U
    J Cardiovasc Comput Tomogr; 2015; 9(3):193-201. PubMed ID: 25846248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of patients with acute coronary syndrome and nonobstructive coronary artery disease.
    Rossini R; Capodanno D; Lettieri C; Musumeci G; Limbruno U; Molfese M; Spatari V; Calabria P; Romano M; Tarantini G; Gavazzi A; Angiolillo DJ
    Am J Cardiol; 2013 Jul; 112(2):150-5. PubMed ID: 23602693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the use of 4 recommended drug categories and patient perceptions of health status following an ACS event.
    Erickson SV; Rangarajan K; Kline-Rogers EM; Smith DE; Eagle KA
    J Manag Care Pharm; 2009 Sep; 15(7):533-42. PubMed ID: 19739876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.